Merck & Co. Inc. (MRK)
-NYSE 45.99 
0.38(0.82%) May 17, 4:00PM EDT|After Hours
:
45.99 0.00 (0.00%) May 17, 6:28PM EDT
| Prev Close: | 46.37 |
|---|
| Open: | 46.29 |
|---|
| Bid: | 45.63 x 200 |
|---|
| Ask: | 46.03 x 200 |
|---|
| 1y Target Est: | 50.11 |
|---|
| Beta: | 0.39 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 45.08 - 46.71 |
|---|
| 52wk Range: | 37.02 - 48.79 |
|---|
| Volume: | 21,737,001 |
|---|
| Avg Vol (3m): | 16,261,500 |
|---|
| Market Cap: | 138.87B |
|---|
| P/E (ttm): | 23.46 |
|---|
| EPS (ttm): | 1.96 |
|---|
| Div & Yield: | 1.72 (3.70%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Oramed Sweeps Past Worldwide Giants With The First Trial Of Orally Delivered Insulinat Seeking Alpha(Sun 4:43PM EDT)
- 1 Great Dividend You Can Buy Right Nowat Motley Fool(Sun 4:30PM EDT)
- Statin Users May Have a Reason to Rejoice After This Dataat Motley Fool(Sun 12:05PM EDT)
- Johnson & Johnson and Merck Lead the Dow Healthcare Stock Rollercoaster Ride This Weekat Wall St. Cheat Sheet(Sun 11:25AM EDT)
- Pick Your Poison: Overweight or High Cholesterolat Motley Fool(Sun 11:00AM EDT)
- AbbVie Investors, Watch This Management Changeat Motley Fool(Sat, May 18)
- The New Generic-Drug Battle Frontat Motley Fool(Sat, May 18)
- Dow Jumps on Virtuous Cycleat Motley Fool(Fri, May 17)
- Oncothyreon A Speculative Buyat Seeking Alpha(Fri, May 17)
- 3 Most Important Upcoming FDA Decisions of 2013at Motley Fool(Fri, May 17)
- Merck to Present at the UBS Global Healthcare ConferenceBusiness Wire(Fri, May 17)
- Why Stocks Are Continuing Their Climbat Motley Fool(Fri, May 17)
- Jennifer Aniston: Movie Star Turned Hair Care Mogulat CNBC(Fri, May 17)
- Strong Consumer Sentiment Pulls Markets Higherat Motley Fool(Fri, May 17)
- Credit Swaps in U.S. Fall as Leading Indicators, Sentiment Riseat Bloomberg(Fri, May 17)
Key Statistics
| Forward P/E (1 yr): | 12.13 |
|---|
| P/S (ttm): | 3.03 |
|---|
| Ex-Dividend Date: | 13-Mar-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.51 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.84 |
|---|
| Mean Recommendation*: | 2.2 |
|---|
| PEG Ratio (5 yr expected): | 5.18 |
|---|
Business Summary
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide.
View More